Post-Budget Summit
The half-day summit will discuss the implications of the Labor federal government's first Budget and the progress of other policy initiatives, including the National Medicines Policy and health technology assessment reviews.
Sydney, Australia
31 October 2022
BPD Annual Conference 2023
'An opportunity for a wider discussion'
The annual event will take place after the 2023-24 Budget. The premier annual conference of the pharmaceutical industry is widening its focus to reflect the alignment of interests across the biopharmaceutical, medical device and diagnostic sectors.
15 May 2022
15 May 2023
Sydney, Australia
Sydney, Australia
'ivy ballroom'
About The Event.
The annual conference of the BioPharmaDispatch publisher, Daily Dispatch, provides a full-day opportunity to discuss the federal government's 2023-24 Budget and other related issues.
Wider consideration of the issues.
The biopharmaceutical, medical device and diagnostic sectors share many of the same issues and challenges. Is there an opportunity for greater collaboration and cross-sector alignment on policy and stakeholder engagement? Is it even possible?
The conference program will be built to provide an engaging, informed and wide-ranging discussion on these and other related issues with the goal to ensure an open dialogue involving patients.
Complimentary registration will be available for patients and their representatives - email contact@dailydispatch.com.au for more information.
+250
+10
Participants
Sessions
Speakers.
Conference Program.
8.30am
Venue opens
8.45 - 9.00am
Official open
Mark Butler MP
Minister for Health and Aged Care
9.00am - 9.30am
Address with Q&A - The Coalition's response to the 2023-24 Budget and its priorities
Senator The Hon. Anne Ruston
Shadow Minister for Health and Aged Care
Shadow Minister for Sport'
9.30am - 10.00am
Panel - The 'good, the not so good, and the opportunities
Adam Roach, Vice President, Head of Asia Pacific, BeiGene
Jaime McCoy, General Manager ANZ, Gilead Sciences
Richard Vines, Founder and CEO, Rare Cancers Australia
10.00am - 10.30am
One-on-one discussion - The campaign against 'double-dispensing'
Professor Trent Twomey, National President, Pharmacy Guild of Australia
10.30am - 11.00am
Break
11.00am - 11.45am
Panel - A shared experience
Kate Holliday, CEO, Centre for Community-Driven Research
Felicity McNeill PSM, Founder and Chair, Better Access Australia
11.45am - 12.40pm
One-on-one discussion - Reflections
Professor Andrew Wilson, Chair, Pharmaceutical Benefits Advisory Committee
12.40pm - 1.30pm
Lunch
1.30pm - 2.10pm
One-on-one discussion - A New Zealand patient perspective
Dr Malcolm Mulholland, Chair, Patient Voice Aotearoa
2.10pm - 3.00pm
Panel - An Australian patient perspective
Ruth Colagiuri AM, Founder and Director, Juvenile Arthritis Foundation Australia
Giulia Jones, CEO, Painaustralia
3.00pm - 3.30pm
Break
3.30pm - 4.15pm
Panel - Lessons from medical devices and diagnostics
Pat Williams, Vice President ANZ, Edwards Lifesciences
Andrea Kunca, Market Access and Public Policy Lead, Roche Diagnostics Australia
4.15pm - 5.00pm
Panel - Where to from here
Liz de Somer, CEO, Medicines Australia
Ian Burgess, CEO, Medical Technology Association of Australia
5.00pm - 6.00pm
Reception
Register.
Register for the BPD Annual Conference 2023